Development of Prodrug 4-Chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}-1,2,4-benzotriazin-7-yl)phenyl Benzoate (TG100801): A Topically Administered Therapeutic Candidate in Clinical Trials for the Treatment of Age-Related Macular Degeneration
2008 ◽
Vol 51
(6)
◽
pp. 1546-1559
◽
Keyword(s):
2015 ◽
Vol 4
(3)
◽
pp. 6
◽
Keyword(s):
2020 ◽
pp. bjophthalmol-2020-316195
◽
Keyword(s):
2005 ◽
Vol 123
(9)
◽
pp. 1283
◽